Baloise Holding AG (ETR:BLON)

Market Cap	9.92B
Revenue (ttm)	6.43B
Net Income (ttm)	410.16M
Shares Out	n/a
EPS (ttm)	9.03
PE Ratio	24.18
Forward PE	19.45
Dividend	8.10 (3.78%)
Ex-Dividend Date	Apr 29, 2025

Volume	n/a
Average Volume	n/a
Open	212.80
Previous Close	211.80
Day's Range	212.80 - 215.40
52-Week Range	155.00 - 215.40
Beta	n/a
RSI	66.61
Earnings Date	Sep 10, 2025

About Revance Therapeutics

Baloise Holding AG, together with its subsidiaries, primarily engages in the insurance and banking businesses in Switzerland, Germany, Belgium, and Luxembourg. It operates through Non-Life, Life, Asset Management & Banking, and Other Activities segments. The Non-Life segment offers accident and health insurance, as well as products relating to liability, motor, property, and marine insurance. The Life segment provides individuals and companies with a range of endowment policies, term insurance, investment-linked products, and private placement ...

• Industry: Other
• Founded: 1863
• Employees: 7,569
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: BLON

Financial Performance

In 2024, Baloise Holding AG's revenue was 6.03 billion, an increase of 4.20% compared to the previous year's 5.79 billion. Earnings were 384.80 million, an increase of 60.60%.